BIOLIFE SOLUTIONS INC (ticker: BLFS) is an NASDAQ-listed clinical biotech company. DredgeCap's structured extraction of BLFS's SEC filings surfaces 5 active risk signals, including 4 late-filing signals, and 1 auditor-change signal. BLFS reported $6.19M in revenue and $1.19M for the period ending 2014-12-31, with operating cash flow of -$491K. Cash and equivalents stood at $22.82M (down 65.9% year-over-year). Total assets of $400.91M exceed total liabilities of $28.68M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
BLFS Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for BIOLIFE SOLUTIONS INC (BLFS) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.